Mutations of epidermal growth factor receptor and K‐ras genes in adenosquamous carcinoma of the lung

Shinichi Toyooka*, Yasushi Yatabe, Masaki Tokumo, Kouichi Ichimura, Hiroaki Asano, Kunitoshi Tomii, Motoi Aoe, Hiroyuki Yanai, Hiroshi Date, Tetsuya Mitsudomi and Nobuyoshi Shimizu Department of Cancer and Thoracic Surgery, Graduate School of Medicine and Dentistry, Okayama University, Okayama 700-8558, Japan Department of Pathology and Molecular Diagnosis, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan Department of Pathology, Graduate School of Medicine and Dentistry, Okayama University, Okayama 700-8558, Japan Department of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan

[1]  S. Toyooka,et al.  The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  Takayuki Kosaka,et al.  Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer , 2004, Cancer Research.

[3]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[4]  J. Minna,et al.  DNA methylation profiles of lung tumors. , 2001, Molecular cancer therapeutics.

[5]  F. Bray,et al.  Cancer burden in the year 2000. The global picture. , 2001, European journal of cancer.

[6]  M. Ebina,et al.  Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung. , 2000, The American journal of pathology.

[7]  Y. Nishiwaki,et al.  Clonal Analysis of Adenosquamous Carcinoma of the Lung , 1999, Japanese journal of cancer research : Gann.

[8]  M. Rooney,et al.  Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J. Minna,et al.  Molecular pathogenesis of lung cancer. , 1994, Annual review of physiology.

[10]  S. Hilsenbeck,et al.  The Increasing Recognition of Adenosquamous Lung Carcinoma (1977–1986) , 1992, American journal of clinical oncology.

[11]  K. Sugimachi,et al.  Adenosquamous carcinoma of the lung. Clinicopathologic and immunohistochemical features. , 1992, American journal of clinical pathology.

[12]  S. Rodenhuis,et al.  K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. , 1990, The New England journal of medicine.

[13]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.